NMC Grand Rounds: Pulmonary Hypertension: A Case-Based Introduction
November 28 @ 12:00 pm - 1:00 pm PSTFree
Presented By: Kristina Kudelko, MD
Pulmonary hypertension still has a horrible prognosis. It’s a progressive disease with no cure. We are much better at identifying and treating it these days, but with the best of therapies, there is at best a 70 percent survival rate at five years. That’s hard. And it affects a lot of young women.
- describe front-line pulmonary hypertension (PH) diagnostic testing
- interpret the importance of accurate phenotyping of the PH patient
- describe the three main class of PH therapy
- recognize the need for prompt referral to PH centers in specific cases